Pelican BioThermal will supply Zuellig's cold chain packaging in Asia
Rollout in 12 countries begins in Vietnam
Life Science Logistics expands its Indianapolis facility
More CII and refrigerated storage
Now, patient relationship management during clinical trials
Be the Partner displays a software platform that allows indirect contact between trial sponsors and patients
Narrow networks for specialty pharmaceuticals: good or bad for patient outcomes?
CVS Health study finds better adherence; but now, a head-to-head commercial test between Amgen and Sanofi PCSK9s may prove definitive
Rep access continues its downward slide in the US, says ZS Associates
Kansas physicians love their rep visits; Wisconsinites, not so much...
Sandoz' filgrastim biosimilar is now on the US market
Initial pricing has a 15% discount off Amgen's Neupogen
SAP will launch a dedicated traceability platform for pharma, applicable globally
Advanced Track and Trace for Pharma could streamline both manufacturing and warehousing data collection and reporting
Maintaining your digital marketing assets
Promotional content produced for, or derived from, digital media presents its own management and compliance complexities
Cold Chain Global Forum takes shape
The IQPC event returns to Boston
Alliance for Safe Biologics issues its response to FDA biosimilars-naming guidance
Expects World Health Organisation to follow FDA's lead
Driving Traceability Requirements to True Business Value
How taking an aggressive and comprehensive approach in 2015 can save millions in 2023
Next-Generation Serialization
Achieving Compliance with Ever-Changing Requirements
FDA decides in favor of innovator biotechs in biosimilar naming conventions
Proposed guidance would offer four-letter suffixes to distinguish original and follow-on biologics
A Conversation with Steve Collis, AmerisourceBergen
FDA approves Amgen's Repatha PCSK9 drug, opening the door to competition with Sanofi's Praluent
Amgen will be 'sensitive to the concerns of payers around cost,' company says
The quality drive at contract manufacturers
Contract development and manufacturing organizations (CDMOs) want to be more reliable business partners to pharma
The 2015 Biopharma Cold Chain Landscape
More volumes of more valuable products drive growth
Pharma is under-managing its multi-channel marketing efforts
Survey shows that most digital channels are still experiments with little oversight or follow-through
Predicting pharma's data-driven future
The business of orphan drugs is booming
With competing products and pricing pressure, the rare disease market is starting to resemble the conventional drug market
J.D. Power pharmacy satisfaction survey: independents on top
Annual survey ranks Good Neighbor Pharmacy as No. 1
Ten integrated imperatives for pharma commercial transformation
The pharma industry needs to go farther in adapting to new marketplace realities
Amarin Pharma v. U.S. Food and Drug Administration: Excerpts
PDI upgrades PD One, its rep-communications platform
New interfaces and real-time analytics
In case you were wondering: the 'rat model' market is worth $358 million globally
Projected to grow 9% (CAGR) through 2020
Accenture highlights new responsibilities for sales reps
A 'rebirth' is in the works
Smartphone assistance for prescribing information, mobilePDR, gets an upgrade
Competition continues with Epocrates for market share of doctors' viewership
How should pharma managers account for improving patient outcomes in their forecasting?
A nice problem to have; ZS Associates looks at the implications in myeloma
Clinical logistics providers World Courier and Marken build out new capabilities
Marken adds real-time wireless tracking; World Courier opens a testing lab in Germany
HPCLC fall meeting set for mid-October in Chicago
Megatrends for healthcare supply-chain management
